Literature DB >> 23108588

Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Asaf Vivante1, Eliezer Golan, Dorit Tzur, Adi Leiba, Amir Tirosh, Karl Skorecki, Ronit Calderon-Margalit.   

Abstract

BACKGROUND: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD.
METHODS: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification.
RESULTS: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (≥95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented.
CONCLUSIONS: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.

Entities:  

Mesh:

Year:  2012        PMID: 23108588      PMCID: PMC4941233          DOI: 10.1001/2013.jamainternmed.85

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  39 in total

1.  The nephrotic syndrome: a complication of massive obesity.

Authors:  J R Weisinger; R L Kempson; F L Eldridge; R S Swenson
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

2.  Predictors of end-stage renal disease and body mass index in a screened cohort.

Authors:  K Iseki; Y Ikemiya; K Fukiyama
Journal:  Kidney Int Suppl       Date:  1997-12       Impact factor: 10.545

3.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

Review 4.  Leptin and renal disease.

Authors:  Gunter Wolf; Sheldon Chen; Dong Cheol Han; Fuad N Ziyadeh
Journal:  Am J Kidney Dis       Date:  2002-01       Impact factor: 8.860

5.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

6.  Heterogeneous nature of renal lesions in type II diabetes.

Authors:  V Gambara; G Mecca; G Remuzzi; T Bertani
Journal:  J Am Soc Nephrol       Date:  1993-02       Impact factor: 10.121

7.  Obesity-related glomerulopathy in China: a case series of 90 patients.

Authors:  Hui-Mei Chen; Shi-Jun Li; Hui-Ping Chen; Qing-Wen Wang; Lei-Shi Li; Zhi-Hong Liu
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

8.  Early predictors of 15-year end-stage renal disease in hypertensive patients.

Authors:  H M Perry; J P Miller; J R Fornoff; J D Baty; M P Sambhi; G Rutan; D W Moskowitz; S E Carmody
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

9.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

Review 10.  Molecular studies of leptin: implications for renal disease.

Authors:  P Stenvinkel; F Lönnqvist; M Schalling
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

View more
  93 in total

1.  Association of body mass index with outcomes in patients with CKD.

Authors:  Jun Ling Lu; Kamyar Kalantar-Zadeh; Jennie Z Ma; L Darryl Quarles; Csaba P Kovesdy
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

2.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  Pediatr Nephrol       Date:  2017-02-01       Impact factor: 3.714

3.  Obesity: High teenage BMI increases ESRD risk.

Authors:  Joana Osório
Journal:  Nat Rev Endocrinol       Date:  2012-11-13       Impact factor: 43.330

4.  Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.

Authors:  Hiroaki Kikuchi; Eiichiro Kanda; Shintaro Mandai; Masanobu Akazawa; Soichiro Iimori; Katsuyuki Oi; Shotaro Naito; Yumi Noda; Takayuki Toda; Teiichi Tamura; Sei Sasaki; Eisei Sohara; Tomokazu Okado; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2016-02-26       Impact factor: 2.801

Review 5.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  J Nephrol       Date:  2017-02       Impact factor: 3.902

6.  Obesity and Kidney Disease: Hidden Consequences of the Epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  Kidney Dis (Basel)       Date:  2017-02-03

7.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

8.  The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors.

Authors:  Marina López-Martínez; Sergio Luis-Lima; Enrique Morales; Maruja Navarro-Díaz; Natalia Negrín-Mena; Tomás Folgueras; Beatriz Escamilla; Sara Estupiñán; Patricia Delgado-Mallén; Domingo Marrero-Miranda; Ana González-Rinne; Rosa María Miquel-Rodríguez; Maria Angeles Cobo-Caso; Laura Díaz-Martín; Alejandro Jiménez-Sosa; Federico González-Rinne; Armando Torres; Esteban Porrini
Journal:  Int J Obes (Lond)       Date:  2019-10-22       Impact factor: 5.095

9.  Obesity increases the risk of renal involvement in children with Henoch-Schönlein purpura.

Authors:  Yong-Li Zhao; Zheng-Juan Liu; Xue-Mei Bai; Yu-Chuan Wang; Guo-Hua Li; Xue-Yan Yan
Journal:  Eur J Pediatr       Date:  2015-04-22       Impact factor: 3.183

10.  Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.

Authors:  Christy B Turer; Tammy M Brady; Sarah D de Ferranti
Journal:  Circulation       Date:  2018-03-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.